Acquisition History / Northwest Biotherapeutics, Inc. / Advent BioServices Ltd.
Northwest Biotherapeutics, Inc. Acquires Advent BioServices Ltd.
Announced April 7, 2026 — $1.9M
What happened
Northwest Biotherapeutics completed the acquisition of its UK contract manufacturer Advent BioServices in April 2026. Consideration was a purchase price of approximately $1.9M (£1.4M) plus payment of the net accounts payable NWBO owed Advent for manufacturing services.
- Acquirer
- Northwest Biotherapeutics, Inc.
- Target
- Advent BioServices Ltd.
- Announced
- April 7, 2026
- Price
- $1.9M
- Industry
- Cell therapy contract manufacturing
- Buyer type
- Strategic acquirer
- Status
- Closed
By the numbers
Frequently Asked Questions About This Acquisition
When did Northwest Biotherapeutics, Inc. acquire Advent BioServices Ltd.?
Northwest Biotherapeutics, Inc. acquired Advent BioServices Ltd. on April 7, 2026. This was Northwest Biotherapeutics, Inc.'s 1st publicly tracked acquisition out of 1 we have on record.
How much did Northwest Biotherapeutics, Inc. pay for Advent BioServices Ltd.?
Northwest Biotherapeutics, Inc. paid $1.9M for Advent BioServices Ltd..
What does Advent BioServices Ltd. do?
Northwest Biotherapeutics completed the acquisition of its UK contract manufacturer Advent BioServices in April 2026. Consideration was a purchase price of approximately $1.9M (£1.4M) plus payment of the net accounts payable NWBO owed Advent for manufacturing services.
What other Cell therapy contract manufacturing companies has Northwest Biotherapeutics, Inc. acquired?
Advent BioServices Ltd. is Northwest Biotherapeutics, Inc.'s only publicly tracked acquisition in Cell therapy contract manufacturing so far.